SALMONELLA-TYPHI VACCINE STRAIN CVD-908 EXPRESSING THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM - STRAIN CONSTRUCTION AND SAFETY AND IMMUNOGENICITY IN HUMANS

被引:99
作者
GONZALEZ, C
HONE, D
NORIEGA, FR
TACKET, CO
DAVIS, JR
LOSONSKY, G
NATARO, JP
HOFFMAN, S
MALIK, A
NARDIN, E
SZTEIN, MB
HEPPNER, DG
FOUTS, TR
ISIBASI, A
LEVINE, MM
机构
[1] UNIV MARYLAND, SCH MED, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
[2] NATL NAVAL MED CTR, BETHESDA, MD 20814 USA
[3] INST MEXICANO SEGURO SOCIAL, UNIDAD INVEST MED & IMMUNOQUIM, MEXICO CITY, DF, MEXICO
[4] NYU, SCH MED, DEPT MED & MOLEC PARASITOL, NEW YORK, NY USA
关键词
D O I
10.1093/infdis/169.4.927
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
rcsp, encoding amino acids 21-398 of Plasmodium falciparum circumsporozoite protein (CSP), under control of P-tac was integrated into the chromosomal Delta aroC locus of attenuated Delta aroC, Delta aroD Salmonella typhi CVD 908. By immunoblot and ELISA, rCSP expression was greater from a multicopy plasmid than from the single chromosomal gene. CVD 908 Omega(Delta aroC1019::P-tac-rcsp) was well tolerated by 10 volunteers who were fed two doses of 5 x 10(7) organisms 8 days apart. Seven subjects excreted the vaccine strain for 1-3 days. All subjects developed serologic responses to O and H antigens of the live vector, whereas 3 vaccinees responded to the foreign antigen: 1 developed an 80-fold rise in serum anti-sporozoite antibody, another had a 4-fold rise in antibody to a recombinant portion of CSP (residues 309-345), while a third vaccinee developed CSP-specific CD8(+) cytotoxic T lymphocyte activity. This is the first report of attenuated S. typhi eliciting a human serologic or a cytotoxic T lymphocyte response to a foreign protein. Improved foreign gene expression should enhance immunogenicity.
引用
收藏
页码:927 / 931
页数:5
相关论文
共 37 条
[21]   Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system [J].
Tacket, CO ;
Kelly, SM ;
Schodel, F ;
Losonsky, G ;
Nataro, JP ;
Edelman, R ;
Levine, MM ;
Curtiss, R .
INFECTION AND IMMUNITY, 1997, 65 (08) :3381-3385
[22]   Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C [J].
Wu, SG ;
Beier, M ;
Sztein, MB ;
Galen, J ;
Pickett, T ;
Holder, AA ;
Gómez-Duarte, OG ;
Levine, MM .
JOURNAL OF BIOTECHNOLOGY, 2000, 83 (1-2) :125-135
[23]   STUDIES OF SAFETY, INFECTIVITY AND IMMUNOGENICITY OF A TEMPERATURE SENSITIVE STRAIN OF SALMONELLA-TYPHI (TS 51-1) AS A NEW LIVE ORAL TYPHOID-FEVER VACCINE CANDIDATE [J].
BELLANTI, JA ;
ZELIGS, BJ ;
HOOKE, AM .
CLINICAL RESEARCH, 1992, 40 (02) :A289-A289
[24]   CONSTRUCTION OF A POTENTIAL BIVALENT VACCINE STRAIN - INTRODUCTION OF SHIGELLA-SONNEI FORM-I ANTIGEN GENES INTO THE GALE SALMONELLA-TYPHI TY21A TYPHOID VACCINE STRAIN [J].
FORMAL, SB ;
BARON, LS ;
KOPECKO, DJ ;
WASHINGTON, O ;
POWELL, C ;
LIFE, CA .
INFECTION AND IMMUNITY, 1981, 34 (03) :746-750
[25]   Attenuated salmonella typhi vaccine strain CVD 908-htrA used as a live vector expressing full-length anthrax protective antigen in a heterologous prime-boost regimen [J].
Magaly, Chinchilla ;
Pasetti, Marcela ;
Wang, Jin ;
Thayil, Seema ;
Arciniega-Martinez, Ivonne ;
Rossini, Aldo ;
Levine, Myron ;
Galen, James .
CLINICAL IMMUNOLOGY, 2008, 127 :S136-S137
[26]   Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy [J].
Chinchilla, Magaly ;
Pasetti, Marcela F. ;
Medina-Moreno, Sandra ;
Wang, Jin Yuan ;
Gomez-Duarte, Oscar G. ;
Stout, Rick ;
Levine, Myron M. ;
Galen, James E. .
INFECTION AND IMMUNITY, 2007, 75 (08) :3769-3779
[27]   SAFETY, IMMUNOGENICITY, AND EFFICACY AGAINST CHOLERA CHALLENGE IN HUMANS OF A TYPHOID-CHOLERA HYBRID VACCINE DERIVED FROM SALMONELLA-TYPHI TY21A [J].
TACKET, CO ;
FORREST, B ;
MORONA, R ;
ATTRIDGE, SR ;
LABROOY, J ;
TALL, BD ;
REYMANN, M ;
ROWLEY, D ;
LEVINE, MM .
INFECTION AND IMMUNITY, 1990, 58 (06) :1620-1627
[28]   Stabilization of a plasmid coding for a heterologous antigen in Salmonella enterica serotype typhi vaccine strain CVD908-htrA by using site-specific recombination [J].
Stephens, Jonathan C. ;
Darsley, Michael J. ;
Turner, Arthur K. .
INFECTION AND IMMUNITY, 2006, 74 (07) :4383-4386
[29]   STUDIES OF SAFETY, INFECTIVITY AND IMMUNOGENICITY OF A NEW TEMPERATURE-SENSITIVE (TS) 51-1 STRAIN OF SALMONELLA-TYPHI AS A NEW LIVE ORAL TYPHOID-FEVER VACCINE CANDIDATE [J].
BELLANTI, JA ;
ZELIGS, BJ ;
VETRO, S ;
PUNG, YH ;
LUCCIOLI, S ;
MALAVASIC, MJ ;
HOOKE, AM ;
UBERTINI, TR ;
VANNI, R ;
NENCIONI, L .
VACCINE, 1993, 11 (05) :587-590
[30]   Development of a Chimeric Plasmodium berghei Strain Expressing the Repeat Region of the P. vivax Circumsporozoite Protein for In Vivo Evaluation of Vaccine Efficacy [J].
Espinosa, Diego A. ;
Yadava, Anjali ;
Angov, Evelina ;
Maurizio, Paul L. ;
Ockenhouse, Christian F. ;
Zavalaa, Fidel .
INFECTION AND IMMUNITY, 2013, 81 (08) :2882-2887